2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 Wiley 2026暑期线上学习营 | 报名正式开启！ | 热 最高IF18.6！生命科学SCI明星期刊集锦 | 热 肿瘤免疫/自身免疫全覆盖｜免疫学SCI期刊列表 |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Hematology & Oncology J HEMATOL ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.4
58人评分
我要评分
声誉 9.1 影响力 8.1 速度 6.9 | |||||||||||||||||||||||||||||
| 期刊ISSN | 1756-8722 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：47.75 | |||||||||||||||||||||||||||||
| 2025-2026自引率 | 1.0%点击查看自引率趋势图 | |||||||||||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 42.696数据由网友[oak5608]收集提供 | |||||||||||||||||||||||||||||
| h-index | 60 | |||||||||||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||||||||||
| 期刊官方网站 | http://jhoonline.biomedcentral.com | |||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||
| 期刊投稿网址 | https://www.springer.com/12481 | |||||||||||||||||||||||||||||
| 作者指南网址 | http://jhoonline.biomedcentral.com/submission-guidelines | |||||||||||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Current and future immunotherapies for NSCLC Author: Zhou, Chu-Yu; Qi, Yi-Fan; Li, Hong-Ji; Zhang, Chao; Lin, Bai-Xin; Lin, Jun-Tao; Wu, Yi-Long; Zheng, Mei-Mei; Zhong, Wen-Zhao Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01791-w Neutrophil extracellular traps in the tumor microenvironment, metastasis, therapy, and beyond: advances, challenges, and perspectives Author: He, Jingwen; Zhou, Zhaokai; Cheng, Guangyang; Li, Huabing; Tu, Jiaqi; Fan, Zixuan; Qiu, Xiuting; Chen, Wenjie; Chen, Yajun; Li, Ling; Li, Chen; Li, Zhengrui; Chen, Lina; Lu, Qiong Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01789-4 CAR-T therapy moving to first-line in multiple myeloma: latest updates from the 2025 ASH annual meeting Author: Geng, Chuanying; Chen, Wenming; Zhu, Hong-Hu Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01793-8 Optimizing next-generation CAR-macrophages against solid tumors: challenges and potential strategies Author: Chen, Yizhao; Zhou, Lucheng; Chen, Xinlei; Wang, Shuai; Chen, Weiwei; Li, Zixuan; Qiu, Ji; Li, Ruilin; Tu, Jiajie; Lin, Ning Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01792-9 | |||||||||||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Hematology & Oncology的语言要求，还能让Journal of Hematology & Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Hematology & Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评（1篇） 论文致谢（6篇） 。
提交文稿 | |||||||||||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ GBP3390; USD4690; EUR3990; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：haematology、oncology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||
| 通讯方式 | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL | |||||||||||||||||||||||||||||
| 出版商 | BioMed Central | |||||||||||||||||||||||||||||
| 涉及的研究方向 | 医学-血液学 | |||||||||||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||||||||||
| 出版周期 | Irregular | |||||||||||||||||||||||||||||
| 出版年份 | 2008 | |||||||||||||||||||||||||||||
| 年文章数 | 75点击查看年文章数趋势图 | |||||||||||||||||||||||||||||
| Gold OA文章占比 | 100.00% | |||||||||||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 45.33% | |||||||||||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||||||||||
  | ||||||||||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1756-8722%5BISSN%5D | |||||||||||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 较慢,6-12周 | |||||||||||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||||||||||
| 版面费/APC文章处理费信息 | 文章处理费：需要（ GBP3390; USD4690; EUR3990; ） 文章处理费豁免：查看说明 其他费用：没有 LetPub提供文章处理费（APC）支持服务，可以用人民币支付版面费啦！ | |||||||||||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Hematology & Oncology顺利发表。
快看看作者怎么说吧：服务好评（1篇） 论文致谢（6篇） 。 提交文稿 | |||||||||||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Current and future immunotherapies for NSCLC Author: Zhou, Chu-Yu; Qi, Yi-Fan; Li, Hong-Ji; Zhang, Chao; Lin, Bai-Xin; Lin, Jun-Tao; Wu, Yi-Long; Zheng, Mei-Mei; Zhong, Wen-Zhao Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01791-w PubMed DOI |
| 2. | Neutrophil extracellular traps in the tumor microenvironment, metastasis, therapy, and beyond: advances, challenges, and perspectives Author: He, Jingwen; Zhou, Zhaokai; Cheng, Guangyang; Li, Huabing; Tu, Jiaqi; Fan, Zixuan; Qiu, Xiuting; Chen, Wenjie; Chen, Yajun; Li, Ling; Li, Chen; Li, Zhengrui; Chen, Lina; Lu, Qiong Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01789-4 PubMed DOI |
| 3. | CAR-T therapy moving to first-line in multiple myeloma: latest updates from the 2025 ASH annual meeting Author: Geng, Chuanying; Chen, Wenming; Zhu, Hong-Hu Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01793-8 PubMed DOI |
| 4. | Optimizing next-generation CAR-macrophages against solid tumors: challenges and potential strategies Author: Chen, Yizhao; Zhou, Lucheng; Chen, Xinlei; Wang, Shuai; Chen, Weiwei; Li, Zixuan; Qiu, Ji; Li, Ruilin; Tu, Jiajie; Lin, Ning Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01792-9 PubMed DOI |
| 5. | Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants Author: Lin, Pao-Yen; Zeng, Bing-Syuan; Chen, Jiann-Jy; Zeng, Bing-Yan; Suen, Mein-Woei; Hung, Chao-Ming; Hsu, Chih-Wei; Stubbs, Brendon; Chen, Yen-Wen; Chen, Tien-Yu; Lei, Wei-Te; Hsu, Shih-Pin; Shiue, Yow-Ling; Su, Kuan-Pin; Li, Cheng-Ta; Wang, Hung-Yu; Tseng, Ping-Tao; Liang, Chih-Sung Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01788-5 PubMed DOI |
| 6. | In vivo CAR-T cell therapy: latest updates from 2025 ASH annual meeting Author: Gao, Pan; Liu, Jun; Ma, Jun; Ma, Hengrui; Zhang, Ya Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01787-6 PubMed DOI |
| 7. | Efficacy and safety of hetrombopag, a novel thrombopoietin receptor agonist, in children and adolescents with immune thrombocytopenia: results from a randomized, multicenter, placebo-controlled phase 3 trial Author: Wu, Runhui; Gao, Ju; Liu, Yufeng; Yu, Jie; Hu, Shaoyan; Liang, Hui; Jiang, Hui; Zhai, Xiaowen; Zhou, Min; Hao, Wenge; Mei, Heng; Li, Fei; Chen, Yumei; Liu, Wei; Yan, Mei; Li, Runzi; Xiong, Junye; Zhu, Zhenyi; Cheng, Xiaoling; Wang, Tianyou Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01790-x PubMed DOI |
| 8. | Immuno-cytotoxic convergence: integrating antibody-drug conjugates and immunofusion proteins to overcome resistance in gastrointestinal cancers Author: Wu, Shenghong; Cui, Ran; Zhao, Kangnan; Yang, Zhen; Yi, Zihan; Cao, Weiwei; Ye, Li Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01795-6 PubMed DOI |
| 9. | CXCR4-antagonistic peptide-decorated lipid nanoparticles for co- delivery of AML1-ETO siRNA to enhance chemotherapy in refractory AML Author: Peng, Xuelu; Gu, Runxia; Wang, Tao; Jiang, Chuanmei; Xing, Haiyan; Meng, Jie; Wen, Tao; Liu, Jian; Wang, Jianxiang; Xu, Haiyan Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01785-8 PubMed DOI |
| 10. | IL-5 CAR-T cell therapy induces effective remission in hypereosinophilic disorders Author: Wu, Youqian; Zhang, Ruiqi; Sun, Beibei; Chen, Gaoying; Xu, Fang; Chen, Xinyi; Zeng, Jiayuan; Shen, Dan; Shi, Fan; Pan, Sheng; Yao, Bingpeng; Tang, Haoyu; Shao, Zhehua; Wu, Qian; Shao, Jiawei; Zhang, Chao; Wang, Dongrui; Hu, Yongxian; Ying, Songmin Journal: JOURNAL OF HEMATOLOGY & ONCOLOGY. 2026; Vol. 19, Issue 1, pp. -. DOI: 10.1186/s13045-026-01782-x PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共5条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
